Qiagen
QGEN
257 hedge funds and large institutions have $5.91B invested in Qiagen in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 84 increasing their positions, 106 reducing their positions, and 48 closing their positions.
1% more call options, than puts
Call options by funds: $56.2M | Put options by funds: $55.5M
0.2% more ownership
Funds ownership: 50.82% → 51.02% (+0.2%)
0% more capital invested
Capital invested by funds: $5.9B → $5.91B (+$10.4M)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
6% less funds holding
Funds holding: 274 → 257 (-17)
21% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 106
31% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 48
Top Buyers
Top Sellers
| 1 |
DKCM
Davidson Kempner Capital Management
New York
|
-$167M |
| 2 |
HM
HealthCor Management
New York
|
-$40.8M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$39.2M |
| 4 |
Goldman Sachs
New York
|
-$27.9M |
| 5 |
SIG
Senator Investment Group
New York
|
-$24.4M |
QGEN Hedge Fund Activity: Q2 2021 in Review
257 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Qiagen (QGEN) for Q2 2021, worth a combined $5.91B — up 0.18% from $5.9B a quarter earlier.
Sellers outnumbered buyers: 48 funds closed out of QGEN and 33 opened new positions — a net loss of 15 holders — while 106 trimmed existing stakes and 84 added.
The largest buyer was Massachusetts Financial Services, adding an estimated $167M. The largest seller was Davidson Kempner Capital Management, cutting an estimated $167M.
- 257 institutional investors held Qiagen (QGEN) as of Q2 2021, down from 274 in Q1 2021.
- Funds reported $5.91B of Qiagen stock for Q2 2021, up 0.18% quarter-over-quarter.
- 33 funds opened new Qiagen positions in Q2 2021 and 48 closed out, a net change of -15 holders.
- The largest Qiagen buyer in Q2 2021 was Massachusetts Financial Services, an estimated $167M added.
- The largest Qiagen seller in Q2 2021 was Davidson Kempner Capital Management, an estimated $167M sold.
Based on aggregated 13F filings for Q2 2021.